$RVP
RETRACTABLE TECHNOLOGIES INC Stock $rvp

$rvp Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000155837022004880 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$59.46M	$188.4M	$32.00M
YoY Change	85.83%	130.12%	153.34%
Cost Of Revenue	$25.14M	$93.03M	$16.02M
YoY Change	56.91%	107.41%	108.57%
Gross Profit	$34.32M	$95.35M	$15.98M
YoY Change	114.82%	157.65%	222.84%
Gross Profit Margin	57.72%	50.62%	49.93%
Selling, General & Admin	$5.632M	$21.86M	$3.518M
YoY Change	60.1%	76.78%	18.41%
% of Gross Profit	16.41%	22.92%	22.02%
Research & Development	$153.9K	$901.4K	$180.0K
YoY Change	-14.52%	56.89%	30.24%
% of Gross Profit	0.45%	0.95%	1.13%
Depreciation & Amortization	$555.0K	$1.257M	$207.1K
YoY Change	168.04%	51.12%	-1.8%
% of Gross Profit	1.62%	1.32%	1.3%
Operating Expenses	$5.786M	$22.76M	$3.693M
YoY Change	56.67%	75.9%	18.78%
Operating Profit	$28.53M	$72.60M	$12.28M
YoY Change	132.31%	201.59%	567.76%
Interest Expense	-$288.9K	$227.2K	$1.227M
YoY Change	-123.54%	-12.71%	5508.46%
% of Operating Profit	-1.01%	0.31%	9.99%
Other Income/Expense, Net	$425.2K	$425.2K
YoY Change
Pretax Income	$28.67M	$74.95M	$13.51M
YoY Change	112.22%	187.46%	625.84%
Income Tax	$7.746M	$18.89M	$2.001M
% Of Pretax Income	27.02%	25.2%	14.81%
Net Earnings	$20.92M	$56.06M	$11.51M
YoY Change	81.82%	131.45%	518.31%
Net Earnings / Revenue	35.19%	29.76%	35.97%
Basic Earnings Per Share		$1.65
Diluted Earnings Per Share	$615.7K	$1.63	$338.6K
COMMON SHARES
Basic Shares Outstanding	33.76M	33.87M
Diluted Shares Outstanding		34.24M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.43M	$42.43M	$25.65M
YoY Change	65.44%	65.44%	87.13%
Cash & Equivalents	$29.16M	$29.16M	$17.57M
Short-Term Investments	$13.27M	$13.27M	$8.082M
Other Short-Term Assets	$702.0K	$702.0K	$684.3K
YoY Change	2.58%	2.58%	7.73%
Inventory	$20.59M	$20.59M	$10.23M
Prepaid Expenses
Receivables	$34.86M	$34.86M	$21.13M
Other Receivables	$5.924M	$5.924M	$0.00
Total Short-Term Assets	$104.5M	$104.5M	$69.48M
YoY Change	50.42%	50.42%	144.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$87.93M	$87.93M	$30.82M
YoY Change	185.32%	184.96%	187.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.87M	$13.87M	$4.637M
YoY Change	199.16%	199.16%	77700.0%
Total Long-Term Assets	$101.8M	$101.8M	$35.49M
YoY Change	186.81%	186.82%	229.52%
TOTAL ASSETS
Total Short-Term Assets	$104.5M	$104.5M	$69.48M
Total Long-Term Assets	$101.8M	$101.8M	$35.49M
Total Assets	$206.3M	$206.3M	$105.0M
YoY Change	96.54%	96.54%	167.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.40M	$20.40M	$16.26M
YoY Change	25.52%	25.52%	224.64%
Accrued Expenses	$5.893M	$5.893M	$4.513M
YoY Change	30.6%	30.6%	135.36%
Deferred Revenue	$2.340M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$289.1K	$289.1K	$1.031M
YoY Change	-71.95%	-71.95%	295.02%
Total Short-Term Liabilities	$35.32M	$35.32M	$27.90M
YoY Change	26.61%	26.61%	237.9%
LONG-TERM LIABILITIES
Long-Term Debt	$1.814M	$1.814M	$2.710M
YoY Change	-33.06%	-33.06%	13.97%
Other Long-Term Liabilities	$70.00M	$70.00M	$24.48M
YoY Change	185.95%	185.95%
Total Long-Term Liabilities	$71.81M	$71.81M	$27.19M
YoY Change	164.12%	164.12%	1043.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.32M	$35.32M	$27.90M
Total Long-Term Liabilities	$71.81M	$71.81M	$27.19M
Total Liabilities	$107.1M	$107.1M	$55.09M
YoY Change	94.47%	94.47%	418.0%
SHAREHOLDERS EQUITY
Retained Earnings	$41.18M		-$9.668M
YoY Change	-525.96%
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock	$63.02M		$59.29M
YoY Change	6.31%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	$528.2K
Shareholders Equity	$99.17M	$99.17M	$49.88M
YoY Change
Total Liabilities & Shareholders Equity	$206.3M	$206.3M	$105.0M
YoY Change	96.54%	96.54%	167.93%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$20.92M	$56.06M	$11.51M
YoY Change	81.82%	131.45%	518.31%
Depreciation, Depletion And Amortization	$555.0K	$1.257M	$207.1K
YoY Change	168.04%	51.12%	-1.8%
Cash From Operating Activities	$14.66M	$32.79M	$10.16M
YoY Change	44.26%	72.62%	1324.81%
INVESTING ACTIVITIES
Capital Expenditures	-$11.85M	$58.37M	-$11.57M
YoY Change	2.45%	177.28%	7890.25%
Acquisitions
YoY Change
Other Investing Activities	$12.34K	-$4.674M	-$67.92K
YoY Change	-118.17%	-371.34%	66.31%
Cash From Investing Activities	-$11.84M	-$63.04M	-$11.64M
YoY Change	1.74%	226.17%	6168.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$29.50K
YoY Change
Debt Paid & Issued, Net		$274.8K
YoY Change		5.33%
Cash From Financing Activities	9.978M	41.84M	3.324M
YoY Change	200.15%	249.79%	-2348.34%
NET CHANGE
Cash From Operating Activities	14.66M	32.79M	10.16M
Cash From Investing Activities	-11.84M	-63.04M	-11.64M
Cash From Financing Activities	9.978M	41.84M	3.324M
Net Change In Cash	12.80M	11.60M	1.850M
YoY Change	591.92%	-0.31%	386.95%
FREE CASH FLOW
Cash From Operating Activities	$14.66M	$32.79M	$10.16M
Capital Expenditures	-$11.85M	$58.37M	-$11.57M
Free Cash Flow	$26.52M	-$25.57M	$21.74M
YoY Change	22.0%	1145.87%	2432.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000946563
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33957204
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-16465
CY2021	dei	Entity Registrant Name EntityRegistrantName	Retractable Technologies, Inc
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-2599762
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	511 Lobo Lane
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Elm
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75068-5295
CY2021	dei	City Area Code CityAreaCode	972
CY2021	dei	Local Phone Number LocalPhoneNumber	294-1010
CY2021	dei	Security12b Title Security12bTitle	Common
CY2021	dei	Trading Symbol TradingSymbol	RVP
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	200031281
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33123205
CY2021	dei	Auditor Name AuditorName	Moss Adams LLP
CY2021	dei	Auditor Location AuditorLocation	Dallas, TX
CY2021	dei	Auditor Firm AuditorFirmId	659
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29162913
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1973781
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3725527
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17566682
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	352217
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	205822
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34859505
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21131841
CY2021Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	5924136
CY2020Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	11779078
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	13268986
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	8081833
CY2021Q4	us-gaap	Inventory Net InventoryNet	20589919
CY2020Q4	us-gaap	Inventory Net InventoryNet	10234646
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	701969
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	684317
CY2021Q4	us-gaap	Assets Current AssetsCurrent	104507428
CY2020Q4	us-gaap	Assets Current AssetsCurrent	69478397
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87925651
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30816504
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13865834
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4631206
CY2021Q4	us-gaap	Other Assets OtherAssets	5675
CY2020Q4	us-gaap	Other Assets OtherAssets	44567
CY2021Q4	us-gaap	Assets Assets	206304588
CY2020Q4	us-gaap	Assets Assets	104970674
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20404573
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16256444
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	289114
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1030763
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1056656
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	826762
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1438371
CY2020Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	49091
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3450684
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3398904
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4959878
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4365770
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35324803
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27901515
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69996330
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24478697
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1814194
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2710337
CY2021Q4	us-gaap	Liabilities Liabilities	107135327
CY2020Q4	us-gaap	Liabilities Liabilities	55090549
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34013104
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33484935
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33957204
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2021Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	63024888
CY2020Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	59285401
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41182429
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9668221
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	528169
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	5270501
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	99169261
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	49880125
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	206304588
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104970674
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188382454
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81862453
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41797179
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	93029933
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44854100
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27659223
CY2021	us-gaap	Gross Profit GrossProfit	95352521
CY2020	us-gaap	Gross Profit GrossProfit	37008353
CY2019	us-gaap	Gross Profit GrossProfit	14137956
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4477651
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4061904
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4217863
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	901381
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	574527
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	516095
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17378301
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8301169
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6432158
CY2021	us-gaap	Operating Expenses OperatingExpenses	22757333
CY2020	us-gaap	Operating Expenses OperatingExpenses	12937600
CY2019	us-gaap	Operating Expenses OperatingExpenses	11166116
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	72595188
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	24070753
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	2971840
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1377652
CY2021	rvp	Other Income Technology Agreement OtherIncomeTechnologyAgreement	425158
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33870819
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33169307
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32672475
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34244699
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33300654
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32672475
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	25613733
CY2019	us-gaap	Dividends Preferred Stock DividendsPreferredStock	219512
CY2019	us-gaap	Net Income Loss NetIncomeLoss	3148234
CY2021	rvp	Interest And Other Income Loss InterestAndOtherIncomeLoss	779996
CY2020	rvp	Interest And Other Income Loss InterestAndOtherIncomeLoss	2262758
CY2019	rvp	Interest And Other Income Loss InterestAndOtherIncomeLoss	351166
CY2021	us-gaap	Interest Expense InterestExpense	227183
CY2020	us-gaap	Interest Expense InterestExpense	260264
CY2019	us-gaap	Interest Expense InterestExpense	166897
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74950811
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26073247
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3156109
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18886570
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1850234
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7875
CY2021	us-gaap	Net Income Loss NetIncomeLoss	56064241
CY2020	us-gaap	Net Income Loss NetIncomeLoss	24223013
CY2019	us-gaap	Net Income Loss NetIncomeLoss	3148234
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	241703
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	573868
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	702618
CY2020	rvp	Deemed Capital Contribution On Extinguishment Of Preferred Stock Income Statement Impact DeemedCapitalContributionOnExtinguishmentOfPreferredStockIncomeStatementImpact	2975708
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	55822538
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26624853
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2445616
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	28542455
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-3489672
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	922512
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	107250
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	210933
CY2020	us-gaap	Net Income Loss NetIncomeLoss	24223013
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	49880125
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48600
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	5213591
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3660387
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5270501
CY2021	us-gaap	Net Income Loss NetIncomeLoss	56064241
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	99169261
CY2021	us-gaap	Profit Loss ProfitLoss	56064241
CY2020	us-gaap	Profit Loss ProfitLoss	24223013
CY2019	us-gaap	Profit Loss ProfitLoss	3148234
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1257417
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	832069
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	852080
CY2021	rvp	Net Equity Securities Fv Unrealized Gain NetEquitySecuritiesFvUnrealizedGain	-513529
CY2020	rvp	Net Equity Securities Fv Unrealized Gain NetEquitySecuritiesFvUnrealizedGain	-1870010
CY2019	rvp	Net Equity Securities Fv Unrealized Gain NetEquitySecuritiesFvUnrealizedGain	-129315
CY2020	rvp	Equity Securities Fair Value Realized Gain EquitySecuritiesFairValueRealizedGain	-162595
CY2019	rvp	Equity Securities Fair Value Realized Gain EquitySecuritiesFairValueRealizedGain	-7925
CY2021	us-gaap	Accretion Expense AccretionExpense	109019
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-9234628
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4631206
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	150000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	59440
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3660387
CY2021	rvp	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	-1377652
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-33140
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13877663
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14626910
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1652015
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10355273
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2784054
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-94502
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	17652
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	49116
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-9602
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-100785
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-100937
CY2021	rvp	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	-38892
CY2020	rvp	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	-43748
CY2019	rvp	Increase Decrease In Other Operating Assets Excluding Other Current Assets IncreaseDecreaseInOtherOperatingAssetsExcludingOtherCurrentAssets	-77541
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4148128
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11248840
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-362072
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2147705
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2232059
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	55150
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	594107
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4347826
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7919
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32793499
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18997029
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2194638
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58366563
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	75000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21049656
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	632078
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4748624
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2242897
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7360398
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	49091
CY2019	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	54800
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3965329
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2712134
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63040187
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19327224
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5280342
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	274791
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	260894
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	407014
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1363000
CY2021	rvp	Proceeds From Technology Investment Agreement ProceedsFromTechnologyInvestmentAgreement	52366282
CY2020	rvp	Proceeds From Technology Investment Agreement ProceedsFromTechnologyInvestmentAgreement	10636822
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	48600
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	922512
CY2021	rvp	Payment Of Preferred Stock Redemption Price Payable PaymentOfPreferredStockRedemptionPricePayable	101250
CY2021	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1101110
CY2020	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	482670
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3824311
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	216642
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	219825
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5270501
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41842919
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11962128
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-626839
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11596231
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11631933
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3712543
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17566682
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5934749
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9647292
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29162913
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17566682
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5934749
CY2021	us-gaap	Interest Paid Net InterestPaidNet	118163
CY2020	us-gaap	Interest Paid Net InterestPaidNet	260264
CY2019	us-gaap	Interest Paid Net InterestPaidNet	166897
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	27124342
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2106000
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1438371
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	30500
CY2020	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	96700
CY2019	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	8500
CY2021	rvp	Amounts Receivable Under Technology Investment Agreement AmountsReceivableUnderTechnologyInvestmentAgreement	5924136
CY2020	rvp	Amounts Receivable Under Technology Investment Agreement AmountsReceivableUnderTechnologyInvestmentAgreement	11779078
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	6000
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	107250
CY2021	rvp	Preferred Stock Repurchase In Noncash Investing And Financing Activities PreferredStockRepurchaseInNoncashInvestingAndFinancingActivities	2132948
CY2020	rvp	Preferred Stock Repurchase In Noncash Investing And Financing Activities PreferredStockRepurchaseInNoncashInvestingAndFinancingActivities	3007002
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 18pt;">Accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. The amount reported as a contractual allowance for rebates involves examination of past historical trends related to sales to customers and the related credits issued once contractual obligations of the customers have been met. The establishment of a liability for future claims of rebates against sales in the current period requires that the Company has an understanding of the relevant sales with respect to product categories, sales distribution channels, and the likelihood of contractual obligations being satisfied.</p>
CY2021	rvp	Number Of Products Consigned To Customer NumberOfProductsConsignedToCustomer	0
CY2021	rvp	Revenue Recognition Period For Return Of Incorrect Shipments RevenueRecognitionPeriodForReturnOfIncorrectShipments	P10D
CY2021	rvp	Revenue Recognition Overstock Return Limit Number RevenueRecognitionOverstockReturnLimitNumber	2
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 18pt;">Concentration risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The Company’s financial instruments exposed to concentrations of credit risk consist primarily of cash, cash equivalents, certificates of deposit, exchange-traded and closed-end funds, mutual funds, equity securities, and accounts receivable. Cash balances, some of which exceed federally insured limits, are maintained in financial institutions; however, Management believes the institutions are of high credit quality. The majority of accounts receivable are due from companies that are well-established entities. The Company assesses market risk in debt and equity securities through consultation with its outside investment advisors. Management is responsible for directing investment activity based on current economic conditions. In 2021, a significant portion of the Company's sales were to the U.S. government, which Management does not consider a credit risk. As a consequence, Management considers any exposure from concentrations of credit risks to be limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;">The following table reflects our significant customers in 2021, 2020, and 2019:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Years Ended December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Number of significant customers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:45.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aggregate dollar amount of net sales to significant customers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">113.7 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">41.6 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">19.0 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:45.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Percentage of net sales to significant customers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">60.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The Company increased its allowance for doubtful accounts by $150 thousand in 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The Company manufactures some of its products in Little Elm, Texas, as well as utilizing manufacturers in China. The Company obtained roughly 92% of its products in 2021 from its Chinese manufacturers. Purchases from Chinese manufacturers aggregated 85.2% and 82.6% of products in 2020 and 2019, respectively. In the event that the Company becomes unable to purchase products from its Chinese manufacturers, the Company would need to find an alternate manufacturer for its blood collection set, IV catheter, Patient Safe<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> syringe, 0.5mL insulin syringe, 0.5mL autodisable syringe, and 2mL, 5mL, and 10mL syringes and would increase domestic production for the 1mL and 3mL syringes and EasyPoint<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> needles. </p>
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-150000
CY2021	rvp	Allowance For Contractual Pricing AllowanceForContractualPricing	6200000
CY2020	rvp	Allowance For Contractual Pricing AllowanceForContractualPricing	3400000
CY2021	rvp	Revenue Recognition Overstock Return Period RevenueRecognitionOverstockReturnPeriod	P12M
CY2021	rvp	Revenue Recognition Maximum Percentage Of Distributors Total Purchase In Prior Twelve Month Period For Overstock Return RevenueRecognitionMaximumPercentageOfDistributorsTotalPurchaseInPriorTwelveMonthPeriodForOverstockReturn	0.01
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188382454
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81862453
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41797179
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	702618
CY2020	rvp	Deemed Capital Contribution On Extinguishment Of Preferred Stock Income Statement Impact DeemedCapitalContributionOnExtinguishmentOfPreferredStockIncomeStatementImpact	2975708
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	141435
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	131347
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	639300
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	232445
CY2021	rvp	Diluted Eps Calculated Under Treasury Stock Method DilutedEpsCalculatedUnderTreasuryStockMethod	373880
CY2020	rvp	Diluted Eps Calculated Under Treasury Stock Method DilutedEpsCalculatedUnderTreasuryStockMethod	131347
CY2019	rvp	Diluted Eps Calculated Under Treasury Stock Method DilutedEpsCalculatedUnderTreasuryStockMethod	639300
CY2021	us-gaap	Net Income Loss NetIncomeLoss	56064241
CY2020	us-gaap	Net Income Loss NetIncomeLoss	24223013
CY2019	us-gaap	Net Income Loss NetIncomeLoss	3148234
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	241703
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	573868
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	55822538
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26624853
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2445616
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33870819
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33169307
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32672475
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34244699
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33300654
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32672475
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	13268986
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	10747733
CY2020Q3	us-gaap	Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred	81029518
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4402828
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1358552
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16187091
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8876094
CY2021Q4	us-gaap	Inventory Net InventoryNet	20589919
CY2020Q4	us-gaap	Inventory Net InventoryNet	10234646
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	13268986
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	8081833
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	2521253
CY2020Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	6082508
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	1999325
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	8081833
CY2021	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	2521253
CY2020	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	1999325
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2710337
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	115509110
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57142546
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27583459
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26326042
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87925651
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30816504
CY2021	us-gaap	Depreciation Depreciation	1257417
CY2020	us-gaap	Depreciation Depreciation	832069
CY2019	us-gaap	Depreciation Depreciation	851673
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	1686868
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	185515
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	2339530
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	331204
CY2021Q4	rvp	Current Portion Of Preferred Stock Repurchase CurrentPortionOfPreferredStockRepurchase	1098282
CY2020Q4	rvp	Current Portion Of Preferred Stock Repurchase CurrentPortionOfPreferredStockRepurchase	1092282
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	102200
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	288550
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3725527
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3398904
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2103308
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	3741100
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	289114
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1030763
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1814194
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	289114
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	304116
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	319682
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	336485
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	353944
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	499967
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2103308
CY2021Q4	rvp	Long Term Deferred Liability Technology Investment Agreement LongTermDeferredLiabilityTechnologyInvestmentAgreement	68955664
CY2020Q4	rvp	Long Term Deferred Liability Technology Investment Agreement LongTermDeferredLiabilityTechnologyInvestmentAgreement	22444324
CY2021Q4	rvp	Long Term Deferred Liability Preferred Stock Redemption Amount LongTermDeferredLiabilityPreferredStockRedemptionAmount	1040666
CY2020Q4	rvp	Long Term Deferred Liability Preferred Stock Redemption Amount LongTermDeferredLiabilityPreferredStockRedemptionAmount	2034373
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69996330
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24478697
CY2021	rvp	Stock Repurchase Liability On Net Present Value StockRepurchaseLiabilityOnNetPresentValue	3303330
CY2021	rvp	Number Of Annual Installment Payments NumberOfAnnualInstallmentPayments	3
CY2021	rvp	Other Long Term Liabilities Purchase Price Payable OtherLongTermLiabilitiesPurchasePricePayable	1101110
CY2021Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Non Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToNonEmployee	8887
CY2020Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Non Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToNonEmployee	8515
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	20041644
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4431590
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8079555
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2049850
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7875
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28121199
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6481440
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7875
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6719211
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3428399
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2515418
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1202807
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9234629
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4631206
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18886570
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1850234
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7875
CY2021	rvp	Income Tax Expense Benefit Attributable To Carry Back Losses IncomeTaxExpenseBenefitAttributableToCarryBackLosses	2000000.0
CY2020	rvp	Income Tax Expense Benefit Attributable To Carry Back Losses IncomeTaxExpenseBenefitAttributableToCarryBackLosses	23300000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	130643
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	198675
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1298083
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	824920
CY2021Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToEmployee	958530
CY2020Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToEmployee	15188
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	118201
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	98748
CY2021Q4	rvp	Deferred Income Technology Investment Agreement Contract DeferredIncomeTechnologyInvestmentAgreementContract	18199768
CY2020Q4	rvp	Deferred Income Technology Investment Agreement Contract DeferredIncomeTechnologyInvestmentAgreementContract	5675617
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20714112
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6821663
CY2021Q4	rvp	Deferred Tax Liabilities Unrealized Gain Losses DeferredTaxLiabilitiesUnrealizedGainLosses	665960
CY2020Q4	rvp	Deferred Tax Liabilities Unrealized Gain Losses DeferredTaxLiabilitiesUnrealizedGainLosses	508197
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	6182318
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1682260
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6848278
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2190457
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13865834
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4631206
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	rvp	Effective Income Tax Value Reconciliation Release Of Valuation Allowance Net Operating Loss Carryforward EffectiveIncomeTaxValueReconciliationReleaseOfValuationAllowanceNetOperatingLossCarryforward	5000000.0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.80
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.064
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.020
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.192
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.356
CY2020	rvp	Effective Income Tax Rate Reconciliation Deferred Tax Assets Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationDeferredTaxAssetsValuationAllowancePercent	-0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2021	rvp	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustments	0.017
CY2020	rvp	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustments	-0.017
CY2019	rvp	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustments	-0.129
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.252
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.071
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	528169
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	405495
CY2021Q2	rvp	Cumulative Annual Payments CumulativeAnnualPayments	5056945
CY2022Q1	rvp	Number Of Entitled Shareholders NumberOfEntitledShareholders	90
CY2022Q1	rvp	Contingent Liability Former Shareholders ContingentLiabilityFormerShareholders	1400000
CY2020	rvp	Preferred Stock Number Of Classes Outstanding PreferredStockNumberOfClassesOutstanding	1
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33484935
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33957204
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	48600
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.21
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0120
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9266
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Maximum Contractual Term1 DeferredCompensationArrangementWithIndividualMaximumContractualTerm1	P3Y
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3660387
CY2021	rvp	Allocated Share Based Compensation Expense Year One AllocatedShareBasedCompensationExpenseYearOne	4595400
CY2021	rvp	Allocated Share Based Compensation Expense Year Two AllocatedShareBasedCompensationExpenseYearTwo	4595400
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1733856
CY2021	rvp	Allocated Share Based Compensation Expense Year Three AllocatedShareBasedCompensationExpenseYearThree	935013
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	842349
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	103312
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	38892
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0
CY2021	rvp	Defined Contribution Plan Employee Service Period DefinedContributionPlanEmployeeServicePeriod	P90D
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.88
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	204032
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	162008
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	117917
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	188382454
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81862453
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41797179
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	87925651
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	30816504
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	32272
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	106101
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38892
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38892
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	38892
CY2021	rvp	Cash Consideration On Repurchase Of Shares Payment Period CashConsiderationOnRepurchaseOfSharesPaymentPeriod	P3Y
CY2021Q1	rvp	Number Of Installments NumberOfInstallments	2
CY2021Q2	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	1377652
CY2020Q3	rvp	Technology Investment Agreement Term TechnologyInvestmentAgreementTerm	P10Y
CY2021	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	46300000
CY2021Q4	rvp	Area Of Land For Existing Properties AreaOfLandForExistingProperties	27800
CY2021Q4	rvp	Area Of Land For New Warehouse AreaOfLandForNewWarehouse	55000
CY2021	rvp	Estimated Cost Of Controlled Environment Within Existing Properties EstimatedCostOfControlledEnvironmentWithinExistingProperties	6700000
CY2021	rvp	Increase Cost Of Controlled Environment Within Manufacturing Equipment IncreaseCostOfControlledEnvironmentWithinManufacturingEquipment	5900000
CY2021	rvp	Estimated Cost Of Construction Of New Warehouse EstimatedCostOfConstructionOfNewWarehouse	17100000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5300000

Files In Submission

Name	View Source	Status
0001558370-22-004880-index-headers.html	Edgar Link	pending
0001558370-22-004880-index.html	Edgar Link	pending
0001558370-22-004880.txt	Edgar Link	pending
0001558370-22-004880-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20211231.xsd	Edgar Link	pending
tmb-20211231x10k.htm	Edgar Link	pending
tmb-20211231x10k001.jpg	Edgar Link	pending
tmb-20211231x10k_htm.xml	Edgar Link	completed
tmb-20211231xex31d1.htm	Edgar Link	pending
tmb-20211231xex31d2.htm	Edgar Link	pending
tmb-20211231xex32.htm	Edgar Link	pending
tmb-20211231xex4dvi.htm	Edgar Link	pending
tmb-20211231_cal.xml	Edgar Link	unprocessable
tmb-20211231_def.xml	Edgar Link	unprocessable
tmb-20211231_lab.xml	Edgar Link	unprocessable
tmb-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RVP
RETRACTABLE TECHNOLOGIES INC Stock $rvp

2021 Q4 Form 10-K Financial Statement

#000155837022004880 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVP RETRACTABLE TECHNOLOGIES INC Stock $rvp

2021 Q4 Form 10-K Financial Statement

#000155837022004880 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVP
RETRACTABLE TECHNOLOGIES INC Stock $rvp